Amylopectin

DB14927ExperimentalSmall molecule

Amylopectin is under investigation in clinical trial NCT01708694 (Role of Slowly Digesible Starch on Diabetes Risk Factors).

Resolves to

Compound
UNII4XO4QFV777CAS9037-22-3
Clinical / RWD
RxNorm1368128

Which companies are running trials of Amylopectin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In